pNaKtide Inhibits Na/K-ATPase Signaling and Attenuates Obesity

Area of Science:

• Biochemistry
• Metabolic Research
• Oxidative Stress

Background:

• Obesity is a global health issue linked to metabolic syndrome.
• Oxidative stress plays a key role in obesity's pathophysiology.
• Na/K-ATPase is known to amplify oxidative stress signaling.

Purpose of the Study:

• To investigate the effect of inhibiting Na/K-ATPase signaling on obesity.
• To evaluate the therapeutic potential of pNaKtide in obesity models.

Main Methods:

• Experiments were conducted using murine preadipocytes and C57Bl6 mice on a high-fat diet.
• The peptide antagonist pNaKtide was used to inhibit Na/K-ATPase.
• Measurements included oxidant stress, lipid accumulation, body weight, systemic inflammation, and insulin sensitivity.

Main Results:

• pNaKtide dose-dependently reduced oxidant stress and lipid accumulation in vitro.
• In obese mice, pNaKtide significantly decreased body weight.
• pNaKtide improved systemic oxidative and inflammatory markers and enhanced insulin sensitivity.

Conclusions:

• Inhibition of Na/K-ATPase signaling with pNaKtide shows therapeutic potential for obesity.
• pNaKtide effectively alleviates obesity and related metabolic comorbidities.
• Targeting Na/K-ATPase oxidant amplification offers a novel strategy for obesity treatment.